...three approved treatments -- Epidiolex cannabidiol from GW Pharmaceuticals plc (NASDAQ:GWPH); Diacomit stiripentol from Laboratoires Biocodex...

...B from new investor SymBiosis LLC and existing investors Seventure Partners, Crédit Mutuel Innovation and Biocodex...

...as CEO, effective June 1. Rohman, who was president of North America operations of Laboratoires Biocodex...

...FDA approved Diacomit stiripentol from Laboratoires Biocodex (Gentilly, France) to treat seizures associated with Dravet syndrome...
...p450) inhibitor. Laboratoires Biocodex, Gentilly, France Product: Diacomit stiripentol Business: Neurology Jaime De Leon Diacomit, stiripentol (ME2080) Laboratoires Biocodex Cytochrome...

...led by new investor Auriga Partners. Fellow new investors Sofimac Innovation, Cap Innov'Est, INRA and Biocodex...

...in a series A round led by Auriga Partners. Sofimac Innovation, Cap Innov'Est, INRA and Biocodex...
...is in preclinical testing for Crohn's disease, ulcerative colitis and irritable bowel syndrome (IBS). Allison Johnson Auriga Partners Biocodex Cap...

...million ($11.5 million) in a series A round from Seventure Partners, CM-CIC Innovation and Laboratoires Biocodex...
...Doré and Mohamad MohtyUniversity collaborators: French National Institute for Agriculture Research (INRA) Corporate partners: Laboratoires Biocodex...

...compared with stiripentol. Next steps include synthesis, optimization and testing of additional stiripentol analogs. Laboratoires Biocodex...

...and South American commercialization rights for Totect dexrazoxane to the Biocodex USA subsidiary of Laboratoires Biocodex...
...of $31.8 million (see BioCentury, March 25). Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Laboratoires Biocodex...